Emblem Corp. (fka EMMBF)

[Werbe]

Yo Lucky. They should be fine if you ask me. What did they use other monies for?

Ninety percent of the net proceeds from the Offering are expected to be allocated toward the currently unfunded portion of the planning, design, development, construction and implementation (including the purchase of certain designated capital equipment) of the Company's new facility which is expected to be comprised of up to approximately 120,000 square feet of greenhouse space and 50,000 square feet of infrastructure space. Although no specific investments are currently contemplated, it is expected that approximately ten percent of the net proceeds will be invested in, among other things, medical marijuana related technologies, seeds, clinical trials, genetics and research and development initiatives or other infrastructure, all within the industry. For additional details regarding the use of proceeds of the Offering, please see the Company's short form amended and restated prospectus dated November 15, 2017 which is available under the Company's profile at SEDAR at www.sedar.com.

Emblem is licensed under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") to cultivate and sell medical marihuana. Emblem carries out its principal activities producing marihuana from its facilities in Paris, Ontario pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.